
    
      This is a randomized, double-blind, parallel controlled, multicenter clinical trial.

      The primary objective is to assess the efficacy similarity of LY09004 and EYLEA in the
      treatment of w-AMD.

      The secondary objective is to assess the safety similarity of LY09004 and EYLEA in the
      treatment of w-AMD.
    
  